James is the CEO and co-founder of PNI, a commercial stage biotechnology company at the convergence of nanotechnology, genomics, and precision medicine. PNI empowers researchers to advance nanomedicines for the treatment and diagnosis of disease. James earned a B.A.Sc. in engineering physics from UBC and a Ph.D. in genetics from the Institute for Systems Biology in Seattle, WA. James worked at the Seattle based Venture Capital firm, the Accelerator Corporation concurrent with his Ph.D. and has extensive experience in the science and commercialization of microfluidics, nanotechnology, and systems biology. James has led PNI since its inception and has grown the Company to be the leading technology provider for the development of nanomedicines. James is a Director of Life Science British Columbia and an active participant of the bio-entrepreneurial community.